Evista patents upheld.
D000818:Animals; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators
D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride